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An exported protein-interacting complex involved
in the trafﬁcking of virulence determinants in
Plasmodium-infected erythrocytes
Steven Batinovic1, Emma McHugh1,*, Scott A. Chisholm2,*, Kathryn Matthews2, Boiyin Liu1, Laure Dumont1,
Sarah C. Charnaud3, Molly Parkyn Schneider1, Paul R. Gilson3, Tania F. de Koning-Ward2, MatthewW.A. Dixon1,**
& Leann Tilley1,**
The malaria parasite, Plasmodium falciparum, displays the P. falciparum erythrocyte membrane
protein 1 (PfEMP1) on the surface of infected red blood cells (RBCs). We here examine the
physical organization of PfEMP1 trafﬁcking intermediates in infected RBCs and determine
interacting partners using an epitope-tagged minimal construct (PfEMP1B). We show that
parasitophorous vacuole (PV)-located PfEMP1B interacts with components of the PTEX
(Plasmodium Translocon of EXported proteins) as well as a novel protein complex, EPIC
(Exported Protein-Interacting Complex). Within the RBC cytoplasm PfEMP1B interacts with
components of the Maurer’s clefts and the RBC chaperonin complex. We deﬁne the EPIC
interactome and, using an inducible knockdown approach, show that depletion of one of its
components, the parasitophorous vacuolar protein-1 (PV1), results in altered knob mor-
phology, reduced cell rigidity and decreased binding to CD36. Accordingly, we show that
deletion of the Plasmodium berghei homologue of PV1 is associated with attenuation of
parasite virulence in vivo.
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P
lasmodium falciparum causes more than 200 million cases
of malaria each year and kills B438,000 people1. The
deaths are due to malaria complications that particularly
affect young children and pregnant women. P. falciparum
develops inside the red blood cells (RBCs) of its human host,
imparting an adhesive phenotype on infected RBCs, leading to
receptor binding on the microvascular endothelium2. Adhesion
sequesters the infected RBCs from the circulation, thereby
preventing the clearance of infected RBCs in the spleen. An
exacerbated inﬂammatory response to the sequestered parasites
can precipitate complications that lead to coma and death3.
Adhesion of P. falciparum-infected RBCs is mediated by a
parasite-derived multiprotein complex containing the major
virulence protein, the P. falciparum erythrocyte membrane
protein-1 (PfEMP1)4,5. PfEMP1 is anchored into knob-like
structures via its C-terminal cytoplasmic domain, the acidic
terminal segment (ATS). The extracellular domains of PfEMP1
contain the variable DBL (Duffy binding-like) and CIDR
(cysteine-rich inter-domain region) domains that facilitate
binding to host receptors6. PfEMP1 is encoded by the
epigenetically controlled 60-member var multigene family7.
Switching expression between different PfEMP1 variants allows
the parasite to change its surface-exposed antigen, thus evading
the host’s protective antibody response8. Therefore, PfEMP1 is
central to both disease pathology and acquisition of immunity;
however, little is known about the export pathways used to trafﬁc
PfEMP1 to the RBC surface.
To reach the host RBC surface, PfEMP1 must be exported
beyond the conﬁnes of the parasite itself; crossing the parasite
plasma membrane (PPM), the parasitophorous vacuole mem-
brane (PVM) and ﬁnally transiting through the RBC cytoplasm.
In the parasitophorous vacuole (PV) it is hypothesized that
PfEMP1 undergoes translocation across the PVM via the PTEX
(Plasmodium Translocon of EXported proteins)9. Indeed,
conditional knockdown of the PTEX components heat shock
protein-101 (HSP101) or PTEX-150 (PTEX150) prevents
PfEMP1 export beyond the PVM10,11. However, it remains to
be determined whether PfEMP1 is a direct substrate for PTEX or
is dependent on other proteins that are exported via PTEX12.
Two previous studies of the PfEMP1 trafﬁcking process have
made use of transfectants expressing genome-integrated green
ﬂuorescent protein (GFP)-tagged minimal PfEMP1 con-
structs13,14. We have used one of these constructs (here
referred to as PfEMP1B). In transfectants expressing PfEMP1B,
a proportion of the chimeric protein is delivered to the RBC
surface13, while some remains associated with intermediate
trafﬁcking compartments, including the PV and the Maurer’s
clefts—a pattern reminiscent of the distribution of endogenous
PfEMP1 (refs 14–17).
Here, we have used immunoprecipitation (IP) and mass
spectrometry to describe the PfEMP1B interactome in different
cellular compartments. We identiﬁed a number of novel
components of the PfEMP1 trafﬁcking pathway, including a
complex of proteins located in the PV. We show that genetic
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Figure 1 | Location and protease accessibility of PfEMP1B during export. (a) Schematic of the minimal PfEMP1 construct, PfEMP1B, used in this study.
PfEMP1B contains the semiconserved head structure from IT4var29, an internal V5 epitope tag, a transmembrane (TM) domain and acidic terminal
segment (ATS) from IT4var3 followed by GFP. Structure of a generic PfEMP1 molecule is shown above. (b) Immunoﬂuorescence analysis of PfEMP1B-
infected RBCs labelled with antisera recognizing GFP (green) and V5 or EXP2 or MAHRP1 (red). Differential interference contrast (DIC) image and parasite
nuclei (stained with DAPI; blue) are shown on the left. White arrows indicate PV-localized PfEMP1B while blue arrows indicate PfEMP1B located at the
Maurer’s clefts. Scale bars, 5mm. (c) Schematic of the protease protection assay performed on PfEMP1B-infected RBCs. Cells were ﬁrst treated with either
saponin, to permeabilize the RBC membrane, the Maurer’s clefts and PVM or with Tetanolysin (Tetano) to permeabilize only the RBC membrane, and then
incubated in the presence or absence of proteinase K (pK). (d) Western blots of the protease-treated infected RBCs were probed with anti-GFP and anti-V5
antisera. SBP1, PV1 and PfGAPDH western blots are shown as controls. Full-length PfEMP1B is indicated with a black arrow and the truncated product with a
grey arrow. Molecular masses are shown in kDa. Uncropped western blots are shown in Supplementary Fig. 12.
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knockdown of the expression of one these components,
parasitophorous vacuolar protein-1 (PV1), compromises host
cell remodelling, decreases adhesion of P. falciparum-infected
RBCs and renders Plasmodium berghei less virulent.
Results
A PfEMP1 chimera accumulates in the PV and Maurer’s clefts.
PfEMP1B contains a semiconserved N-terminal head domain
(NTS, DBL and CIDR segments), a transmembrane (TM) domain
and a conserved acidic terminal segment domain (Fig. 1a),
enabling successful delivery to the RBC surface13. The GFP and
V5 epitope tags on PfEMP1B are recognized in transgenic
parasites expressing the chimera in a compartment with a
‘necklace of beads’ proﬁle at the parasite periphery (Fig. 1b; white
arrows), as well as in punctate structures in the RBC cytoplasm
(Fig. 1b; blue arrows), in agreement with a previous report13.
These compartments respectively represent the PV (where there
is partial co-localization with PTEX component exported protein-
2 (EXP2)) and the Maurer’s clefts (co-localization with Maurer’s
cleft protein membrane-associated histidine-rich protein-1
(MAHRP1)) (Fig. 1b). Dual immunoﬂuorescence labelling with
HSP101, ring-exported protein-1 (REX1) and membrane-
associated histidine-rich protein-2 (MAHRP2) also showed
patterns consistent with those observed for endogenous
PfEMP1 (Supplementary Fig. 1a)14,17–19.
PV-located PfEMP1B is not membrane embedded. To investi-
gate the physical organization of PfEMP1B in the different
compartments we performed a protease protection assay16,20.
Samples were treated with either saponin, known to permeabilize
the RBC, Maurer’s cleft and PV membranes21 or Tetanolysin
(Tetano) that permeabilizes the RBC membrane but leaves both
the Maurer’s clefts and PVM intact22, and incubated with or
without proteinase K (schematic in Fig. 1c). In the absence of
proteinase K, full-length PfEMP1B is recognized as a band of
B175 kDa by antisera recognizing the GFP and V5 epitope tags
(located on opposite sides of the TM domain) (Fig. 1d, black
arrows). Upon treatment with proteinase K, most PfEMP1B is
digested leaving a small amount of the full-length protein
(Fig. 1d). This remnant full-length PfEMP1B represents a
population that is fully protected (that is, in the parasite or
PV). In addition, a truncated fragment was detected at a size of
90–95 kDa using V5 antisera after treatment with Tetanolysin
(Fig. 1d, grey arrow). This fragment is consistent with protection
of the N-terminal domain of PfEMP1 embedded within the
Maurer’s clefts16. Upon treatment with saponin, which is known
to permeabilize the Maurer’s clefts and PVM but leave the PPM
intact21, the remaining full-length PfEMP1B is degraded by
proteinase K (Fig. 1d). This indicates the presence of a population
of nonmembrane embedded PfEMP1B in the PV. The
effectiveness of the Tetanolysin and saponin treatments were
tested by probing membranes with antisera raised against
Maurer’s cleft protein skeleton-binding protein-1 (SBP1), PV1
and PfGAPDH (Fig. 1d, lower panels)23–25. Cleavage of SBP1
following Tetanolysin and saponin treatment is consistent with
previous studies26. Cleavage of PV1 following saponin but not
Tetanolysin treatment is consistent with integrity of the PVM
following Tetanolysin treatment, while protection of PfGAPDH
demonstrates the integrity of the PPM in both treatments.
We additionally performed an immunoﬂuorescence experi-
ment to determine the accessibility of epitopes to antibodies
following saponin treatment of cells in suspension27
(Supplementary Fig. 1b). PV-located PfEMP1B was labelled
with GFP or V5 antisera following saponin treatment
(Supplementary Fig. 1c).
PfEMP1B interacts with components of the PTEX translocon.
We questioned whether the PV-located population of PfEMP1B
was in the process of export via PTEX. We ﬁrst performed a
proximity ligation assay (PLA) to determine whether PfEMP1B is
located close to PTEX. PfEMP1B transfectant-infected RBCs that
were co-labelled with anti-GFP and anti-HSP101 antisera pro-
duced a PLA signal at the parasite periphery (Fig. 2a), demon-
strating close proximity of PfEMP1B and HSP101 in the PV.
Interestingly, a PfEMP1B signal was also observed in regions
distinct from the region of the PLA signal, indicating the majority
of PfEMP1B may reside in a separate compartment in the PV.
Conversely, the control reaction using GFP antisera alone dis-
played PfEMP1B labelling but no PLA signal (Fig. 2a).
To investigate whether PfEMP1B interacts directly with PTEX
components we performed IP using GFP-Trap. To control for
nonspeciﬁc interactions we used a nonsecreted GFP-tagged
minimal PfEMP1 (here termed PfEMP1F)13 and an unrelated
PV-located GFP-reporter (EXP11-35-GFP) (Fig. 2b)28. IP of the
different GFP fusion proteins was demonstrated by western blot
(Supplementary Fig. 2a). A speciﬁc interaction between PfEMP1B
and PTEX was supported by the pull-down of HSP101 and EXP2
with PfEMP1B, but not with PfEMP1F and EXP11-35-GFP
controls (Fig. 2c).
PfEMP1B interacts with SBP1 and REX1 at the Maurer’s clefts.
Given that PfEMP1 transits via the Maurer’s clefts en route to the
infected RBC surface, we again made use of PfEMP1B co-
immunoprecipitation to identify PfEMP1 interactions occurring
in these structures. We employed increasing concentrations of a
membrane-permeable reversible amine-reactive crosslinker, DSP
(dithiobis[succinimidyl propionate]), to enrich weaker protein
interactions during IP. Pull-down of both SBP1 and REX1 was
observed with PfEMP1B but not with the PfEMP1F chimera
(Fig. 2d). The level of REX1 pull-down was found to increase
(410-fold) in the presence of DSP, suggesting a weaker or
indirect interaction with PfEMP1B. The speciﬁcity of these
reactions was conﬁrmed by performing the reverse experiment
using antibodies raised against SBP1 and REX1 to pull-down
crosslinked PfEMP1B (Fig. 2e). PLA analysis reveals close
proximity of these proteins in the Maurer’s clefts (Supplementary
Fig. 2b), indicating that this is the location of these interactions.
Host and parasite proteins that interact with PfEMP1B. We
used mass spectrometry to investigate global PfEMP1B interac-
tions. A portion of protein eluates from PfEMP1B and PfEMP1F
pull-downs were resolved by SDS–polyacrylamide gel electro-
phoresis (SDS-PAGE) and silver stained. Numerous protein
bands were visualized in both PfEMP1F and PfEMP1B samples
including full-length PfEMP1F and PfEMP1B migrating at their
respective molecular masses of 52 and 175 kDa (Fig. 3a; black
arrows). An enrichment of protein bands was observed in the
PfEMP1B sample (Fig. 3a; examples marked with asterisks).
Tandem mass spectrometry (MS/MS) analysis of the remaining
eluates identiﬁed 66 parasite and human proteins that pre-
ferentially interact with PfEMP1B (two independent experiments;
Supplementary Tables 1 and 2).
We categorized peptides based on the localization or function
of parent proteins and found PfEMP1B pulled down proteins
from all known compartments in its export pathway (Fig. 3b). All
ﬁve validated components of PTEX (PTEX150, HSP101, EXP2,
PTEX-88 (PTEX88) and thioredoxin-2 (TRX2)) were detected9.
We normalized the MS/MS spectral counts representing peptides
from PTEX proteins to the size of the respective proteins as a
semiquantitative measure of the interaction afﬁnity with
PfEMP1B and found HSP101 to be the most strongly associated
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PTEX component (Fig. 3c). Eleven exported parasite proteins
(Supplementary Table 1) were detected, including SBP1 and
REX1 in good agreement with our western blot and PLA data
(Fig. 2d,e and Supplementary Fig. 2b) and other proteins such as
MAHRP1 and PfEMP1-trafﬁcking protein-5 (PTP5), consistent
with known roles of these proteins in PfEMP1 export29,30. We
provide further evidence for an interaction between endogenous
PfEMP1 and MAHRP1, MAHRP2 and PTP5 by IP of GFP-tagged
parasite lines (Supplementary Fig. 3a–c). We also performed dual
labelling of PTP5-GFP transfectants using anti-GFP and anti-
SBP1 antisera to demonstrate that PTP5 is located at the Maurer’s
clefts (Supplementary Fig. 3d).
A number of human proteins were also pulled down with
PfEMP1B but not PfEMP1F (Fig. 3d and Supplementary Table 2).
Eight components of the human chaperonin complex, the TCP-1
ring complex (TRiC), a known interaction partner of TRiC,
HSP90 and a regulatory subunit of the 26S proteasome were
found to be the most enriched human proteins (Fig. 3e)31. TRiC
is a eukaryotic ATPase system responsible for the folding of
multiple substrate cargo proteins32–34, and may interact in a
promiscuous fashion with unfolded exported proteins.
Characterization of P. falciparum PV proteins. Given that
PfEMP1B was found to accumulate in the PV, we used this
construct as a tool to decipher additional export events in this
compartment. In our mass spectrometric analysis, we found that
in addition to PTEX, PfEMP1B pulled down another PV-localized
protein, PV1 (Supplementary Table 1)25. Immunoﬂuorescence
and western blot analysis conﬁrmed the close association of PV1
and PfEMP1B (Supplementary Fig. 3e,f). To functionally assess
the interaction between PfEMP1 and PV1, we generated a
haemagglutinin (HA)-tagged inducible knockdown transgenic
parasite line of PV1 using the glmS riboswitch system (Fig. 4a and
Supplementary Fig. 4a)35. We similarly produced inducible
knockdown lines for two additional PfEMP1B-interacting
proteins, PF3D7_1226900 and PF3D7_1024800. We refer to
these proteins as parasitophorous vacuolar protein-2 (PV2) and
exported protein-3 (EXP3), respectively (Fig. 4a). These proteins
have predicted secretory signal sequences but no Plasmodium
export element (PEXEL) sequence (Fig. 4a). Integration of the
PV1, PV2 and EXP3 glmS vectors into the endogenous loci was
conﬁrmed by PCR analysis (Supplementary Fig. 4b) and the
expression of these HA-fusion proteins assessed by western blot.
Protein bands consistent with the predicted sizes of the mature
PV1-HA (52 kDa), PV2-HA (59 kDa) and EXP3-HA (173 kDa)
were observed (Fig. 4b). Immunoﬂuorescence microscopy using
anti-HA antisera conﬁrmed that PV1-HA, PV2-HA and EXP3-
HA are directed to the PV and co-localize with PV1 (Fig. 4c).
Solubility analysis indicated that PV1 and PV2 were largely
soluble in sodium carbonate buffer while EXP3 was only soluble
in Triton X-100, consistent with its predicted transmembrane
domain (Supplementary Fig. 5).
A new protein complex located in the PV of P. falciparum.
Given the co-localization and solubility proﬁles of PV1, PV2 and
EXP3, we performed blue native (BN)-PAGE analysis to inves-
tigate whether these proteins formed a protein complex.
A dominant band migrating between 1,048 and 1,236 kDa was
observed in all three transfectant lines (Fig. 5a, black arrow),
suggesting that the proteins participate in a large protein com-
plex. We refer to this complex as the EPIC (Exported Protein-
Interacting Complex). PV1 and PV2 were also found to be pre-
sent in smaller molecular mass complexes (see full-length gel in
Supplementary Fig. 6a). We occasionally observed an anti-HA-
labelled complex higher (41,236 kDa) than the dominant EPIC
complex in PV1-HA and EXP3-HA samples (Fig. 5a, grey arrow),
reminiscent of the previously described native PTEX com-
plex36,37. To determine the relationship between EPIC and PTEX
complexes, EXP3-HA BN-PAGE samples were probed with anti-
HA and anti-HSP101 antisera. A small population of EXP3-HA
was detected in the PTEX complex as recognized by anti-HSP101
antisera (Fig. 5b, grey arrow), while the majority was present in
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Uncropped western blots are shown in Supplementary Fig. 12.
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EPIC (Fig. 5b, black arrow), suggesting that components of EPIC
may shuttle between complexes.
Components of EPIC co-localize and co-precipitate with PTEX.
We further examined the interaction of EPIC proteins with PTEX
by performing immunoﬂuorescence microscopy. PV1, PV2 and
EXP3 each show a high level of co-localization with HSP101 and
EXP2 in the PV (Fig. 5c and Supplementary Fig. 6b). PV1-HA was
additionally found to co-localize with HSP101 in merozoites
(Supplementary Fig. 6c), suggesting that like PTEX components,
PV1 is synthesized in schizonts and delivered to the PV during or
shortly after invasion36. We next performed IP experiments with
PV1-HA, PV2-HA and EXP3-HA transfectants using anti-HA-
conjugated agarose beads. Both PV2-HA and EXP3-HA pulled
down PV1 (Fig. 5d–f), in agreement with the immunoﬂuorescence
and BN-PAGE analysis. For each EPIC protein, an interaction with
the PTEX components, HSP101 and EXP2, was demonstrated in
transfectant lines but not in the wild type (Fig. 5d–f). Furthermore,
Pf113, a recently described PTEX-associated protein37, was pulled
down with PV1-HA. The interaction of PV1 with PTEX proteins is
in good agreement with a previous report37. In contrast, PfGAPDH
was not present in any of the eluates (Fig. 5d–f).
Global mass spectrometric analysis reveals EPIC interactome.
To dissect the interactome of the EPIC, we performed mass
spectrometric analysis on IP eluates from the three HA-tagged
EPIC components. We identiﬁed 66 parasite proteins that pre-
ferentially interact with EPIC components (two independent
experiments; Supplementary Tables 3–5). Proteins that were
pulled down by all three EPIC components included PTEX
components PTEX150, HSP101, PTEX88 and EXP2, merozoite
surface protein-9 and exported proteins PIESP2 and FIKK 10.1
(Fig. 6a–c). The identiﬁcation of these and other exported pro-
teins in the EPIC pull-downs suggests a possible role for EPIC in
preparing exported proteins for export through PTEX
(Supplementary Tables 3–5). Proteins known to reside in the PV,
including merozoite surface proteins and Ser-repeat antigens
were also pulled down with one or more EPIC components.
Endoplasmic reticulum (ER) and exported Hsp70s (Hsp70-2 and
Hsp70-x) were found to be signiﬁcantly enriched in PV1-HA
eluates compared with the cytoplasmic Hsp70 (Hsp70-1), sug-
gesting an interplay between EPIC and these chaperones
(Fig. 6d,e).
Knockdown of EPIC proteins does not affect parasite viability.
To examine the role of EPIC we made use of the glmS riboswitch
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present in the PV1-HA, PV2-HA and EXP3-HA glmS transfec-
tants (Fig. 4a). In the presence of the cofactor glucosamine-6-
phosphate, the glmS ribozyme degrades mRNA encoding the
targeted gene, reducing its expression35. We treated synchronous
trophozoite-stage (26–34 h post invasion (h.p.i.)) transfectants
with glucosamine (0 to 5mM) and observed a dose-dependent
knockdown of PV1-HA, PV2-HA and EXP3-HA in the
subsequent cycle (Fig. 7a and Supplementary Fig. 7a,b; 86–96%
apparent reduction in the signal at 2.5mM). To determine
whether EPIC components are required for growth in vitro,
synchronous trophozoites (30–32 h.p.i.) were treated with
glucosamine (0mM or 2.5mM) continuously for two
consecutive asexual parasite cycles. No difference in growth was
observed relative to the parental lines, indicating that EPIC
components are either not essential or only needed in low
amounts for normal growth in vitro (Supplementary Fig. 8).
PV1 knockdown disrupts infected RBC remodelling. To assess
effects on the display of adhesins on the infected RBC surface we
panned PV1-HA, PV2-HA and EXP3-HA glmS transfectants on
immobilized CD36 to enrich the population for CD36-binding
variants, and then examined their ability to adhere to immobi-
lized CD36 under physiological ﬂow conditions. Knockdown of
PV1-HA glmS parasites with 2.5mM glucosamine decreased the
binding to CD36 compared with untreated parasites (73±6%
s.e.m., n¼ 5, P¼ 0.002 according to Student’s t-test; Fig. 7b),
indicating that physiological levels of PV1 are needed for efﬁcient
adhesion to endothelial ligands. Glucosamine treatment had no
effect on the 3D7 parent. No signiﬁcant changes in adhesion to
CD36 were observed for the PV2-HA and EXP3-HA glmS
transfectant lines upon treatment with 2.5mM glucosamine
compared with the parental A4 strain (Supplementary Fig. 9a,b).
To further assess the virulence phenotype of PV1-HA glmS
parasites after knockdown, we probed their physical deform-
ability by subjecting infected RBCs (23–26 h.p.i.) to ﬁltration
through a bed of microbeads38. Knockdown of PV1-HA glmS
parasites with 2.5mM glucosamine led to a marked increase in
cellular ﬁlterability (48±6% ﬂow-through) compared with
untreated parasites (26±4% ﬂow-through; n¼ 6, P¼ 0.01
according to Student’s t-test; Fig. 7c). In contrast, treatment
of the parent line with 2.5mM glucosamine had no effect on
ﬁlterability (Fig. 7c).
To determine the molecular basis for the decreased cytoad-
herence and cellular rigidity, we used immunoﬂuorescence signals
as a semiquantitative measure of the level of protein export in the
PV1 knockdown. Treatment of PV1-HA glmS with 2.5mM
glucosamine led to a signiﬁcant decrease in the normalized
ﬂuorescence intensity of PfEMP1 (63%±8% of nontreated
control; nZ15; P¼ 0.006 according to Student’s t-test), KAHRP
(67%±4.8% of nontreated control; nZ56; P¼ 0.001 according to
Student’s t-test) and PfEMP3 (80%±6% of nontreated control;
nZ26; P¼ 0.009 according to Student’s t-test) (Fig. 7d–f;
Supplementary Fig. 9c–e). We next investigated knob morphol-
ogy by scanning electron microscopy. PV1-HA glmS parasites
treated with 2.5mM glucosamine showed an increase in knob size
(108±2 nm) compared with untreated (95±2 nm) (n¼ 6 cells,
4430 measurements, P¼ 0.003 according to Student’s t-test)
(Fig. 7g,h), while no signiﬁcant difference in knob size was
observed upon treatment of the 3D7 parent (Fig. 7g,h). Taken
together, these data indicate that PV1 is needed for efﬁcient
export of proteins that play important roles in remodelling the
host RBC membrane skeleton.
Loss of virulence upon genetic disruption of P. berghei PV1.
The P. berghei rodent model has been validated as a suitable tool
to analyse factors involved in malaria virulence11,39. The
P. berghei homologues of PV1 (PBANKA_0919100), PV2
(PBANKA_1441700) and EXP3 (PBANKA_0509000) were
targeted for deletion. The targeting constructs (Supplementary
Fig. 10a) were designed to integrate into the endogenous
P. berghei loci by double crossover homologous recombination
such that successful replacement of the targeted gene would result
in expression of ﬂuorescent mCherry protein under the
endogenous promoter. All three loci were successfully targeted
as conﬁrmed by PCR (Supplementary Fig. 10b) and live cell
imaging (Supplementary Fig. 10c).
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Two experiments were performed whereby C57BL/6 mice
(n¼ 6 and n¼ 11 per group) were infected with 1 106 wild-type
PbANKA or PbDPV1, PbDPV2 or PbDEXP3 parasites. Tail blood
was analysed daily from 3 days post infection by ﬂow cytometry,
revealing the parasitaemia of the mice infected with the knockout
parasites remained similar to those infected with wild-type
parasites as determined by an unpaired t-test (Fig. 7i;
Supplementary Fig. 11a–c). Thus PbPV1, PbPV2 and PbEXP3
are not essential for parasite replication in vivo. The development
of cerebral malaria symptoms was also monitored in these mice.
Two separate clones of mice infected with PbDPV1 parasites
succumbed to cerebral malaria 2–4 days later than mice infected
with wild-type PbANKA (PbANKA 5–7 days post infection,
PbDPV1 7–9 days post infection) (Fig. 7j and Supplementary
Fig. 11c). Statistical analysis of parasite survival was performed
using a log-rank test (clone 1, n¼ 11, clone 2, n¼ 6 for PbANKA;
clone 1 n¼ 10, clone 2, n¼ 6 for PbDPV1), indicating a
signiﬁcant difference between treatment groups (Po0.0001 and
P¼ 0.0006), suggesting that PbPV1 contributes to parasite
virulence. No difference in survival was observed in mice infected
with PbDPV2 and PbDEXP3 parasites (Supplementary Fig. 11b).
Discussion
Despite the importance of PfEMP1 in both the pathology of
malaria and as a target for protective immunity, the mechanism
and route for trafﬁcking of this adhesin to the RBC surface is
poorly understood. We have made use of a PfEMP1 minimal
construct (PfEMP1B) that we have previously shown accumulates
in two compartments en route to the RBC surface, namely in a
‘necklace of beads’ compartment at the parasite periphery and at
the Maurer’s clefts in the RBC cytoplasm14, as is the case for
endogenous PfEMP1 (refs 16,17). We found that the PV-localized
PfEMP1B population is nonmembrane embedded. In agreement
with a previous report that showed that PfEMP1 is carbonate
extractable during transit through the parasite secretory system40,
our data indicate PfEMP1 is only inserted into the membrane
IP: anti-HA
WT PV2-HA
Input IPInput IP
αPV1
39
39
97
51
51
αHSP101
αHA
αPV1
αEXP2
αPf GAPDH
IP: anti-HA
WT EXP3-HA
Input IPInput IP
39
39
97
51
191
IP: anti-HA
WT PV1-HA
Input IPInput IP
51
αHA
αHSP101
αEXP2
αPf GAPDH
αHA
αHSP101
αEXP2
αPf GAPDH
97
39
αPf 113
191
DIC/DAPI αHA αHSP101 Merge
DIC/DAPI αHA αHSP101 Merge
DIC/DAPI αHA αEXP2 Merge
PV
1-
H
A
PV
2-
H
A
EX
P3
-
H
A
EXP3-HAPV2-HAPV1-HA
1,048
1,236
EXP3-HA
1,048
1,236
αHA αHSP101
a
b
c
d e f
39
Figure 5 | Identiﬁcation of a novel PV protein complex that interacts with PTEX. (a,b) Blue native (BN)-PAGE analysis of PV1-HA-, PV2-HA- and EXP3-
HA-infected RBCs. Western blots were probed with (a,b) anti-HA and (b) anti-HSP101 antisera. Black and grey arrows indicate different size protein
complexes. (c) Immunoﬂuorescence analysis of PV1-HA-, PV2-HA- and EXP3-HA-infected RBCs labelled with antisera recognizing HA (green) and HSP101
or EXP2 (red). DIC and DAPI (blue) are shown on the left. Scale bars, 5 mm. (d–f) Immunoprecipitation of PV1-HA, PV2-HA and EXP3-HA parasite lysates
using anti-HA-conjugated agarose beads. Total protein (input) and eluate (IP) were prepared for western blot and probed with (d–f) anti-HA, anti-HSP101,
anti-EXP2, (d) anti-Pf113 and (e,f) anti-PV1 antisera. Membranes were probed with anti-PfGAPDH antisera as a negative control. (a,b,d–f) Molecular
masses are shown in kDa. Uncropped western blots are shown in Supplementary Fig. 12.
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms16044 ARTICLE
NATURE COMMUNICATIONS | 8:16044 | DOI: 10.1038/ncomms16044 |www.nature.com/naturecommunications 7
when it reaches the Maurer’s clefts. This is in contrast to other
PEXEL-negative exported proteins (PNEPs), which are
incorporated into the ER membrane and require extraction
from the PPM to permit export across the PVM22,41. PfEMP1 has
a much larger molecular mass than most PNEPs that may
preclude membrane insertion and extraction.
Given the extensive repertoire of exported proteins required for
efﬁcient PfEMP1 trafﬁcking12, the speciﬁc requirement for PTEX
in PfEMP1 export has remained uncertain. Here, we provide
evidence of a close interaction between PfEMP1 and PTEX, and
corroborate suggestions that PEXEL and PEXEL-negative protein
trafﬁcking pathways converge in the PV10,11,22,41. In addition, our
semiquantitative analysis of PfEMP1B IPs indicated that
PfEMP1B is most strongly associated with HSP101. This is
consistent with the ability of HSP101 to bind protein cargo
separate from PTEX10 that may occur as early as in the ER42.
Despite these interactions, we observed only modest
immunoﬂuorescence overlap (or PLA signal) between PfEMP1B
and HSP101 or EXP2, similar to that observed with endogenous
PfEMP1 (ref. 17). This may indicate that PfEMP1, upon entry
into the PV, is not relayed directly to the PTEX but instead at
least part of the population is maintained in discrete holding or
sorting sites before translocation across the PVM. Analysis of the
lateral mobility of PV components has suggested the presence of
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distinct subcompartments within the PV43. It is possible these
compartments provide preferential access to PTEX.
We have identiﬁed a parasite protein complex that may help
facilitate protein export in these privileged PV compartments.
The 1.1MDa EPIC comprises at least three proteins; a previously
identiﬁed PTEX-associated protein, PV1 (refs 25,37,44), and two,
previously uncharacterized proteins, here termed PV2 and EXP3.
Given the molecular masses of these individual proteins, it is
likely one or more of these components exist as oligomers, or that
other proteins are present in this complex. We demonstrated that
EPIC components associate with PTEX, suggesting an interplay
between these two complexes. We observed an extensive protein
interaction network contiguous with EPIC, and hypothesize that
EPIC is involved in the movement of cargo to appropriate PV
subcompartments, representing a nexus for protein sorting in the
PV. In the case of exported proteins, this may involve facilitating
transfer to PTEX. Indeed, the majority of exported proteins
pulled down with EPIC have peak expression in early- to mid-
stage trophozoites (when IPs were performed) consistent with
active transport of these proteins in the PV. This concept of
facilitated sorting in the PV is consistent with the inability of
position-5 PEXEL mutants to be exported into the host RBC
despite successful entry into the PV45–48, and provides an
explanation for the convergence of the PEXEL and PEXEL-
negative trafﬁcking pathways in the PV10,11,22,41.
We used the glmS ribozyme/riboswitch to examine the effect of
knockdown of the EPIC components. A previous report indicated
that PV1 could not be genetically ablated in P. falciparum44. We
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observed no signiﬁcant parasite growth retardation upon
knockdown of EPIC components in vitro in P. falciparum or
knockout in vivo in P. berghei. Further work is required to
determine the reason for this apparent discrepancy. Mice infected
with PbDPV1 parasites, however, succumbed to cerebral malaria
later than wild-type parasites, indicating PV1 does indeed
contribute to parasite virulence. Given the association of EPIC
with exported proteins, we probed for deﬁciencies in protein
export. Analysis of ﬂuorescence intensities in age-matched
infected RBCs showed a signiﬁcant decrease in KAHRP,
PfEMP1 and PfEMP3 ﬂuorescence at the RBC membrane upon
knockdown of PfPV1. Associated with this we observed an
increase in cellular deformability with a twofold increase in ability
of infected RBCs to pass through a ﬁlter designed to mimic
splenic fenestrations. In addition, we observed a 29% reduction in
the adhesion of infected RBCs to the endothelial ligand CD36
under physiologically relevant conditions. Modiﬁcations that
stiffen the RBC membrane facilitate adhesion to endothelial cell
ligands by distributing the tensional forces49. We propose that the
loss of PV1 results in the inefﬁcient export or altered timing of
export of PfEMP1 and of proteins that drive remodelling of the
host RBC membrane, with a consequent reduction in cellular
rigidity and reduced cytoadhesion. The relatively mild phenotype
may indicate some level of redundancy in virulence protein
export pathways.
It has been suggested that Plasmodium spp. make use of
human chaperone proteins to aid in the export of parasite
proteins50–52. We detected a signiﬁcant complement of human
proteins in our PfEMP1B co-immunoprecipitations. Most of
these host proteins belonged to the type II chaperonin complex
known as TRiC; a large multi-subunit complex involved in
folding proteins in an ATP-dependant manner. TRiC has been
shown to remain functional in mature RBCs53 and we suggest
that PfEMP1 (and likely other exported cargo) represents a
substrate for its activity. TRiC may function in conjunction with
structures known as J-dots52,54. It has been suggested that
ER
Parasite cytoplasm
PV
RBC cytoplasm
Tether M
AHRP2
EDVs
PTP1
REX1
SBP1
MAHRP1
PTP5PIESP2
PTEX
PV2 PV2
EXP3
PV1
EPIC
Export to RBCOther trafficking
pathways PV1
Unfolded Pf EMP1 
Folded Pf EMP1
SEC63
SEC62
SEC61
Pf j2
PDI-11
huTRiC
Actin network
HSP
101
PTEX
150
EXP2
Knob
Maurer’s cleft
Figure 8 | Model of PfEMP1 export. Schematic proposed model of PfEMP1 export mechanisms based on this study. We propose that PfEMP1 is
translocated into the ER via a SEC61-62-63-mediated pathway and trafﬁcs through the secretory system with the aid of ER-resident chaperones. Upon
secretion into the PV, we propose that PfEMP1 is recognized by EPIC and transported to PTEX for export to the RBC. EPIC may also be responsible for the
targeting of other cargo to alternate trafﬁcking pathways. After crossing the PVM, we propose that PfEMP1 is received by human TRiC and relayed to the
Maurer’s clefts, and that Maurer’s cleft-resident proteins are involved in stabilizing PfEMP1 at the Maurer’s clefts and targeting it to tethers and/or EDVs for
export towards the RBC plasma membrane and insertion into knobs. ER, endoplasmic reticulum; PV, parasitophorous vacuole; EPIC, exported protein-
interacting complex; PTEX, Plasmodium translocon of exported proteins; huTRIC, human TCP1 ring complex; RBC, red blood cell; EDV, electron-dense
vesicle.
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms16044
10 NATURE COMMUNICATIONS | 8:16044 |DOI: 10.1038/ncomms16044 |www.nature.com/naturecommunications
parasite-encoded TRiC (PfTRiC) is also exported into the host
RBC55. In agreement with another recent report56, we were not
able to detect any peptides corresponding to PfTRiC components
in our co-immunoprecipitations, arguing against a role for
PfTRiC in PfEMP1 export.
The Maurer’s clefts represent an intermediate compartment in
the export of PfEMP1 to the infected RBC surface. We found that
SBP1 and REX1, and other Maurer’s cleft proteins, interact with
PfEMP1 at these structures, consistent with studies showing that
the genetic disruption of Maurer’s cleft proteins attenuates
PfEMP1 surface presentation23,57–59. The hydrophobic segment
in PfEMP1 is short and has a lower hydropathy index than
conventional TM segments40, and it is possible that Maurer’s cleft
transmembrane proteins (such as SBP1, MAHRP1 and PTP1
(refs 18,26,30,60)) are needed for docking, insertion and
stabilization of a membrane-embedded form of PfEMP1 at the
Maurer’s clefts. Interestingly, we also observed an interaction of
both PfEMP1B and endogenous PfEMP1 with MAHRP2. This is
consistent with immuno-ultrastructural evidence showing
PfEMP1 association with tethers14, and points to a potential
role for these structures in delivering PfEMP1 to the RBC surface.
In conclusion, we have performed a large-scale protein
interaction analysis of PfEMP1. We have identiﬁed a number of
proteins that interact with PfEMP1 across multiple export
compartments from the ER to the PV, to the RBC cytoplasm,
and the Maurer’s clefts. These data provide signiﬁcant insights
into the pathway for PfEMP1 export. As summarized in the
proposed model presented in Fig. 8, we have described a novel
complex (EPIC) in the PV that may play a role in delivering
proteins in an unfolded state from ER/PV chaperones to PTEX.
We show that PV-located PfEMP1 is not membrane embedded
and demonstrate an interaction of both PfEMP1 and EPIC with
PTEX, consistent with delivery of exported proteins to this
transporter. We also show an interaction of PfEMP1 with the host
chaperonin complex and propose a mechanism for transfer of
PfEMP1 to the Maurer’s clefts. We identify Maurer’s cleft and
tether proteins that interact with PfEMP1 and propose a potential
path for delivery of the adhesin to the RBC surface. Moreover, we
show that components of this pathway are conserved between
P. falciparum and P. berghei and are needed for efﬁcient
cytoadherence and virulence. These insights may translate into
ways to inhibit the presentation of virulence protein on infected
RBCs, and thus ways of interfering with this lethal pathogen.
Methods
Parasite culture. P. falciparum parasites were cultured as previously described61.
Parasites were cultured in Oþ RBC (Australian Red Cross Blood Service) in RPMI
with GlutaMAX (Invitrogen) supplemented with 5% human serum (Australian Red
Cross Blood Service) and 0.25% AlbuMAX II (Invitrogen). For P. falciparum
transfections, ring stage 3D7 (ref. 62) or A4 (ref. 63) strain parasites were
electroporated with 100 mg plasmid as previously described64. Parasites were
maintained on 5 nM WR99210 (Sigma) and cycled in the presence and absence of
WR99210 to select for integration into the genome. For P. berghei transfections,
knockout vectors were ﬁrst digested with SacII and XhoI before transfection into
wild-type P. berghei ANKA (clone 15cy1)65. Pyrimethamine (0.07mgml 1) was
added to the drinking water of mice 1 day post transfection to select for parasites
harbouring the knockout vectors. After veriﬁcation of vector integration, parasite
lines were cloned by intravenous injection of a single parasite into the tail vein of
BALB/c mice and gene deletion was conﬁrmed by analytical PCR.
Transgenic parasites. P. falciparum parasites expressing PfEMP1B, PfEMP1F,
EXP11-35-GFP and MAHRP2-GFP were generated previously13,19,43. Ribozyme-
inducible knockdown constructs were generated by PCR ampliﬁcation of the last
B1,000 bp of the PfPV1 (PF3D7_1129100), PfPV2 (PF3D7_1226900) and PfEXP3
(PF3D7_1024800) genes. PCR products were ligated into pGlmS-3HA59 to
generate ﬁnal targeting vectors. P. berghei gene deletions were generated by PCR
ampliﬁcation of B1.2 kb regions upstream and downstream of the PbPV1, PbPV2
and PbEXP3 coding regions. PCR products were ligated into pBAT66 to generate
ﬁnal knockout vectors. GFP-tagged exported proteins expressed under the control
of the CRT promoter were generated by PCR ampliﬁcation of full-length
PfMAHRP1 (PF3D7_1370300) and PfPTP5 (PF3D7_1002100) genes, minus the
stop codon. PCR products were ligated into pGLUX67 to generate ﬁnal expression
vectors and transfected into P. falciparum 3D7 parasites. Oligonucleotide
sequences used in this study are shown in Supplementary Table 6. The parent lines
for transfection were P. falciparum 3D7 (PfPV1, PfMAHRP1 and PfPTP5), A4
(PfPV2 and PfEXP3) and P. berhei ANKA (PbPV1, PbPV2 and PbEXP3).
Fluorescence microscopy. Immunoﬂuorescence microscopy was performed on
thin blood smears ﬁxed in ice-cold 90% acetone/10% methanol for 5min. Primary
antibodies used included: anti-GFP (mouse, 1:500, Cat. No. 11814460001, Roche),
anti-GFP (rabbit, 1:500)68, anti-V5 (mouse, 1:200, Cat. No. R960-25, Invitrogen),
anti-HA (mouse, 1:200, Cat. No. H3663, Sigma), anti-EXP2 (rabbit, 1:500)9, anti-
HSP101 (rabbit, 1:200)9, anti-MAHRP1 (mouse, 1:500)18 and anti-PV1 (rabbit,
1:200)25. Primary antibodies were detected using Alexa Fluor 488 or 647 secondary
antibodies (goat, 1:1,000, Cat. No. A11001, A11008, A21235, A21244, Invitrogen).
Parasite nuclei were stained with 2 mgml 1 DAPI (40-6-diamidino-2-
phenylindole). PLA was performed according to the manufacturer’s guidelines
using the Duolink in situ PLA probes and far-red detection reagent (OLink
Bioscience). Microscopy was performed on a DeltaVision Elite restorative wideﬁeld
deconvolution imaging system (Applied Precision). Live cell imaging of P. berghei
was performed using a IX71 microscope (Olympus). Samples were excited using
390, 475 or 632 nm solid-state illumination and imaged using band-pass ﬁlters at
435, 523 or 676 nm. Images were taken and deconvoluted using Softworx 5.0
(Applied Precision) and processed using ImageJ software (NIH). Data are
presented as average projections of whole-cell Z-stacks with brightness and
contrast adjustment. Fluorescence quantiﬁcation was performed using ImageJ on
maximum projection images of whole-cell Z-stacks and the mean ﬂuorescence
intensity calculated. For PfEMP1 and KAHRP a 70 70 pixel square
corresponding to the whole infected RBC was used. For PfEMP3 a 30 30 pixel
square was chosen to avoid the nonspeciﬁc parasite staining. The measurements
were normalized to PfGAPDH ﬂuorescence as an internal control. The ﬁnal values
displayed have been adjusted setting the nontreated groups at 100%. The number
of individual cells (n) measured is shown in the ﬁgure legends.
For subcellular localization immunoﬂuorescence microscopy, labelling of
saponin-lysed infected RBCs was performed according to published methods27.
Infected RBCs were ﬁrst afﬁxed to slides using Concanavalin A for 15min before
washing three times with phosphate-buffered saline (PBS)14. Cells were then lightly
ﬁxed in 0.2% formaldehyde added to a solution of 0.015% saponin in PBS for
30min at 4 C. After triplicate washing of wells with PBS, primary and secondary
antibodies were added as above.
Protein gel electrophoresis and immunoblotting. For SDS-PAGE, protein
samples were separated on 4–12% Bolt Bis-Tris gels (Invitrogen) and transferred to
0.2 mm nitrocellulose membrane using the iBlot system (Invitrogen). Membranes
were blocked in 4% skim milk in PBS overnight at 4 C. Membranes were probed
with the following primary antibodies: anti-GFP (mouse, 1:1,000, Cat. No.
11814460001, Roche), anti-V5 (mouse, 1:500, Cat. No. R960-25, Invitrogen), anti-
SBP1 (rabbit, 1:1,000)23, anti-GAPDH (rabbit, 1:2,000)24, anti-HSP101 (mouse,
1:100)9, anti-EXP2 (rabbit, 1:1,000)9, anti-REX1 (rabbit, 1:1,000)69, anti-HA
(rabbit, 1:500, Sigma), anti-Pf113 (rabbit, 1:1,000)37, anti-PV1 (rabbit, 1:1,000)25,
anti-Hsp70-2 (mouse, 1:1,000, a kind gift from Gregory Blatch) and anti-Hsp70-x
(rabbit, 1:1,000)54. Horseradish peroxidase-conjugated secondary antibodies used
were anti-mouse (goat, 1:25,000, Cat. No. W4021, Promega) and anti-rabbit (goat,
1:25,000, Cat. No. W4011, Promega). Membranes were incubated with Clarity ECL
substrate (Bio-Rad) and imaged using the LAS-3000 imaging system (Fuji).
Uncropped immunoblots are presented in Supplementary Fig. 12.
Native protein analysis. Mid-trophozoite stage parasites were saponin-lysed and
solubilized in 0.5% Triton X-100 for 30min on ice. The supernatant was diluted in
NativePAGE sample buffer (Novex) and Coomassie Brilliant Blue G-250 (0.25% v/
v ﬁnal). Protein samples were separated on 3–12% NativePAGE Bis-Tris gels
(Invitrogen) and transferred to 0.2 mm polyvinylidene diﬂuoride membrane using
the iBlot system (Invitrogen). Membranes were stained with 0.1% Coomassie R-250
in 50% methanol, 7% acetic acid to mark protein standards and subsequently
destained in 50% methanol, 7% acetic acid followed by 90% methanol and 10%
acetic acid. Immunoblotting was performed as above.
Protein solubility analysis. Late trophozoite stage puriﬁed infected RBCs were
ﬁrst subject to hypotonic lysis by resuspension in 10 volumes of ice-cold 2mM
Tris-HCl with complete protease inhibitors (Roche) and incubated for 30min on
ice. The suspension was then clariﬁed at 16,000 g for 10min at 4 C. The
supernatant was carefully transferred to a new tube and stored on ice. The pellet
was washed three times in PBS and resuspended in 300 ml ice-cold PBS and 100ml
was aliquoted into three tubes. The suspension was again centrifuged at 16,000 g
for 10min at 4 C and the supernatant discarded. The resulting pellets were
resuspended in 20 volumes of either 0.1M sodium bicarbonate (Na2CO3, pH 11),
5M urea or 1% (v/v) Triton X-100 (TX-100) in PBS with complete protease
inhibitors (Roche) and incubated for 30min on ice (or room temperature for 5M
urea extraction). The suspensions were then centrifuged at 16,000 g for 10min at
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4 C. The supernatants were carefully transferred to new tubes and stored on ice.
The pellets were washed three times in PBS. All soluble and insoluble fractions
were subject to SDS-PAGE and Western blot.
Protease protection assay. Magnet-puriﬁed infected RBCs that were treated with
either 0.05% saponin or 3U of the pore-forming toxin, Tetanolysin, for 10min at
room temperature with shaking at 600 r.p.m. Aliquots were then treated with
20mgml 1 proteinase K for 20min at 37 C or with PBS. A complete protease
inhibitor cocktail (Roche) and phenylmethylsulfonyl ﬂuoride (1mM) was added
for a further 3min. After centrifugation at 5,000 g, the pellets were resuspended
in reducing sample buffer and analysed by western blotting.
Immunoprecipitation. IPs were performed on synchronous mid-trophozoite stage
parasites enriched by gelatin ﬂotation or collected with 0.05% saponin in PBS.
When stated, enriched trophozoites were ﬁrst treated with 0.5–1mM DSP (Pierce)
for 30min. Parasite pellets were solubilized in 10 volumes of IP buffer (1% (v/v)
Triton X-100, 150mM NaCl, 50mM Tris-HCl, pH 7.4) containing complete
protease inhibitors (Roche) for 30min on ice. Clariﬁed lysates were precleared with
50ml protein-A conjugated agarose beads for 30min and then applied to 25 ml
GFP-Trap (Cat. No. gta-20 Chromotek) or monoclonal anti-HA-agarose (Cat. No.
A2905 Sigma) for 4 h or overnight. For IPs using noncommercial matrices,
P. falciparum-speciﬁc antisera were incubated overnight with clariﬁed lysates fol-
lowed by addition of protein-A agarose beads and a further 2 h of incubation. All
IP reactions were washed 5 times with 1ml IP buffer. For immunoblotting, bound
proteins were eluted from beads in 1 LDS sample buffer. Precleared supernatants
were loaded as input lanes (cf. 0.1–2% of eluate lanes) to demonstrate equal
parasite material was used in IPs. For mass spectrometry, reactions were further
washed twice with 1mM Tris-HCl pH 7.4 and eluted in 20% (v/v) TFE (2,2,2-
Triﬂuroethanol) in 0.1% formic acid pH 2.4. After separation of eluate from
agarose beads, the pH was neutralized with TEAB (tetraethylammonium bromide)
and 5mM tris(carboxyethyl)phosphine (TCEP) was added. Samples were digested
with proteomics grade trypsin (Sigma) overnight.
Mass spectrometry. Samples were analysed in triplicate by liquid chromato-
graphy (LC) MS/MS using a LTQ Orbitrap Elite (Thermo Scientiﬁc) with a nano-
electrospray interface coupled to an Ultimate 3,000 RSCL nanosystem (Dionex).
The nano-LC system was equipped with an Acclaim Pepmap nano-trap column
and an Acclaim Pepmap analytical column. A total of 2 ml of the peptide mix was
loaded onto the trap column at 3% CH3CN containing 0.1% formic acid for 5min
before enrichment column was switched in-line with the analytical column. The LC
gradient was 3 to 25% acetonitrile over 20min, and then 40% acetonitrile over the
next 2min (total run time was 38min). The LTQ Orbitrap Elite mass spectrometer
was operated in the data-dependent mode, spectra acquired ﬁrst in positive mode
at 240 k resolution followed by collision-induced dissociation fragmentation.
Twenty of the most intense peptide ions with charge states Z2 were isolated and
fragmented using normalized collision energy of 35 and activation Q of 0.25
(collision-induced dissociation). Mass-spectra (ProteoWizard) were searched
against a custom UniProt database containing both the Homo sapiens and
P. falciparum proteomes using MASCOT (Matrix Science). Searches were based on
the following criteria for peptide identiﬁcation: (1) trypsin as digestion enzyme,
(2) up to three missed cleavages, (3) 5 p.p.m. peptide tolerance and 0.2Da fragment
tolerance and (4) oxidation of methionine and reduced DSP crosslink on lysine or
N terminus as variable modiﬁcations. An initial signiﬁcance threshold of Po0.05
based on a reversed decoy database was used. Peptide searches were reanalysed
using the Percolator algorithm to improve the rate of conﬁdent peptide identiﬁ-
cation70. Protein identiﬁcations were considered valid if Z2 unique peptide
sequences were detected. Statistically signiﬁcant peptide matches corresponding to
speciﬁc protein hits in bait IP reactions (or alternatively, enriched ﬁvefold
compared with the control) were collated into tables ordered based on fold-change
enrichment. Proteins without a signal peptide were excluded from PV1-HA, PV2-
HA and EXP3-HA analysis. For charting, the number of peptides displayed
represents the average number of peptide matches across all replicates and
experiments.
PfEMP1 cytoadherence assay. For up-selection of CD36-binding PfEMP1 var-
iants, recombinant human CD36 (125 mgml 1 in PBS, R&D Systems) was ﬁrst
immobilized on plastic Petri dishes. Gelatin-puriﬁed infected RBCs (1% haema-
tocrit) in bicarbonate-free RPMI-HEPES were added and incubated for 1 h at
37 C. Unbound cells were washed away with bicarbonate-free RPMI-HEPES, and
then fresh culture media and RBCs were added and the dish returned to normal
culture conditions. Binding assays under constant ﬂow conditions were performed
in culture channel chambers (iBidi) coated with recombinant human CD36
(125 mgml 1 in PBS). Chambers were blocked in 1% bovine serum albumin in
PBS for 1 h at 37 C. Binding assays were performed on synchronized trophozoites
(30–34 h.p.i.) that had been treated with glucosamine in the previous cycle.
Infected RBCs (1% haematocrit, 3% parasitaemia) were resuspended in bicarbo-
nate-free RPMI and ﬂowed through the chambers at 0.1 Pa using a Harvard Elite
11 syringe pump. Assays were performed at 37 C and visualized on a DeltaVision
Elite restorative wideﬁeld deconvolution imaging system (Applied Precision) using
a 60 objective. Cultures were ﬂowed through the chamber for 5min and sub-
sequently washed in bicarbonate-free RPMI-HEPES for 10min under constant
ﬂow conditions. The number of bound cells per ﬁeld was counted for 10 pre-
determined ﬁelds.
Cellular ﬁltration. Spleen-mimic ﬁltration assays were performed according to
published methods38,71. Metal microbeads of two different sizes, 5–15 mm and
15–25 mm (96.5% tin, 3% silver and 0.5% copper; Heraeus), were resuspended in
1% AlbuMax II in PBS and layered into an inverted 1ml ﬁlter tip to obtain a bead
bed of 5mm. Filtration was performed on synchronized (23–26 h.p.i.) PV1-HA
glmS- or 3D7-infected RBCs atB5% parasitaemia, 1% haematocrit in 1% AlbuMax
II in PBS. Parasites were incubated from 16 h in the previous cycle in the presence
or absence of 2.5mM glucosamine to achieve efﬁcient protein knockdown. The
cells were ﬂowed over the bead bed and the percentage of transiting parasites
determined by Giemsa analysis of thin smears.
Scanning electron microscopy. Collected trophozoite-infected RBCs were
washed once in PBS before ﬁxation with 1% glutaraldehyde for 15min at room
temperature. Fixed cells were washed once in water, placed on a glass coverslip,
air-dried and sputtered with a 5 nm gold layer as described previously72.
Backscattered electrons were detected using a Teneo VolumeScope scanning
electron microscope (FEI) at 2 kV and 50 pA. Flat cell surfaces were cropped for
knob size analysis. The cropped images were subjected to both high-pass and
low-pass ﬁlters in ImageJ (NIH) to correct brightness gradient and background
noises, respectively. Automatic thresholding was applied to segment the electron
dense knobs and sizes were assessed using Analyze Particles tool in ImageJ as
Feret diameters73. Data were collected for 450 knobs from each cell and was
curated to remove any features 460 nm or 4150 nm to determine the average
knob size per cells. The knob sizes of individual cells (n) measured is shown in
the ﬁgure legends.
P. falciparum growth assay. Synchronized trophozoites (30–32 h.p.i.) were seeded
into 24-well plates (1% haematocrit, 0.5% parasitaemia) and treated with gluco-
samine (0mM or 2.5mM) in triplicate. Culture media and glucosamine were
replenished daily and parasitaemia readjusted to 0.5% on days 2 and 4. Trophozoite
parasitaemia was determined by ﬂow cytometry with a FACSCanto II (BD Bios-
ciences) using SYTO 61 red ﬂuorescence nucleic acid stain (Invitrogen). Thin
blood smears were taken daily and stained with Giemsa to determine parasite
progression through the lifecycle.
Mouse infection studies. Female C57/BL6 mice (n¼ 6–11 mice per group;
Animal Resources Centre, Western Australia) at 6 weeks of age were infected
intraperitoneally with 1 106 PbDPV1, PbDPV2 or PbDEXP3 parasites or
PbANKA wild-type parasites as a control. From 3 days post infection, para-
sitaemias were monitored daily by Giemsa-stained tail blood smears. To assess
parasite virulence, mice were monitored for cerebral malaria symptoms including
ataxia and inability to self-right from day 4 post infection74. Mice were humanely
killed when displaying cerebral malaria symptoms or when the parasitaemia
exceeded 20%. All experiments involving the use of animals were performed in
strict accordance with the recommendations of the Australian Government and the
National Health and Medical Research Council Australian code of practice for the
care and use of animals for scientiﬁc purposes. The protocols were approved by the
Deakin University Animal Welfare Committee (approval number G37/2013 and
G16/2014).
Assessment of cerebral malaria symptoms. The criteria for scoring cerebral
malaria are based on published protocol74. There is a progression of symptoms, but
mice were scored each time for the following: rufﬂed fur, hunching, wobbly gait,
limb paralysis (including inability to self-right), convulsions and coma. Each
symptom was assigned a score of 1. Only when mice scored a cumulative score of
Z4 were they humanely killed. Two researchers independently performed the
scoring.
Statistical analysis. Statistical analysis and graphing were performed using Prism
6 (GraphPad) and Prism 7 (GraphPad). P values of o0.05 were considered
signiﬁcant.
Data availability. The mass spectrometry proteomics data have been deposited to
the ProteomeXchange Consortium via the PRIDE75 partner repository with the
data set identiﬁer PXD006155. All other relevant data are available from the
authors on request.
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